- Home
- EDSA
EDSA
Edesa Biotech Inc.
as 11-15-2024 4:00pm EST
Edesa Biotech Inc is a biotechnology company focused on inflammatory and immune-related diseases. It is involved in exploring novel ways to treat these diseases, including alternatives to topical steroids, which can have side effects. The company's product candidate, EB01, is a non-steroidal, anti-inflammatory treatment for chronic allergic contact dermatitis. The company operates in a single segment: research and development, manufacturing, and commercialization of innovative pharmaceutical products. The company's EB05 candidate is a monoclonal antibody therapy for hospitalized COVID-19 patients.
| Founded: | 2015 | Country: | Canada |
| Employees: | N/A | City: | MARKHAM |
| Market Cap: | 11.0M | IPO Year: | N/A |
| Target Price: | $21.00 | AVG Volume (30 days): | 50.3K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 1 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -2.20 | EPS Growth: | N/A |
| 52 Week Low/High: | $2.09 - $6.46 | Next Earning Date: | 12-13-2024 |
| Revenue: | N/A | Revenue Growth: | N/A |
| Revenue Growth (this year): | N/A | Revenue Growth (next year): | N/A |
Latest Edesa Biotech Inc. News
EDSA Breaking Stock News: Dive into EDSA Ticker-Specific Updates for Smart Investing
GlobeNewswire
17 days ago
Edesa Biotech’s Founder Makes Strategic Investment in the Company
GlobeNewswire
a month ago
Edesa Biotech Announces Upcoming Conference Schedule
Zacks Small Cap Research
3 months ago
EDSA: EB05 Selected for BARDA-Funded Study in ARDS…
ACCESSWIRE
5 months ago
BARDA Selects Edesa Biotech's Drug for U.S. Funded Platform Trial in General ARDS
Zacks Small Cap Research
6 months ago
EDSA: Preparing IND for Phase 2 Trial of EB06 in Vitiligo
ACCESSWIRE
6 months ago
Edesa Biotech Reports Fiscal 2nd Quarter 2024 Results
ACCESSWIRE
7 months ago
Edesa Biotech to Participate in Bloom Burton Healthcare Investor Conference
ACCESSWIRE
7 months ago
Edesa Biotech to Participate in Upcoming Investor Conferences
Compare EDSA vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "EDSA Edesa Biotech Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.